Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response

BACKGROUND: Differently from HIV-1, HIV-2 disease progression usually takes decades without antiretroviral therapy and the majority of HIV-2 infected individuals survive as elite controllers with normal CD4(+) T cell counts and low or undetectable plasma viral load. Neutralizing antibodies (Nabs) ar...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rocha, Cheila, Calado, Rita, Borrego, Pedro, Marcelino, José Maria, Bártolo, Inês, Rosado, Lino, Cavaco-Silva, Patrícia, Gomes, Perpétua, Família, Carlos, Quintas, Alexandre, Skar, Helena, Leitner, Thomas, Barroso, Helena, Taveira, Nuno
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4016255/
https://ncbi.nlm.nih.gov/pubmed/24156513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-4690-10-110
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars